People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Beeken BioMedical, LLC | — | Biotechnology | Series A | $10.8M | $228.9M | 2016 |
Charles Blixt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Blixt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Kendall | 1 | 2 |
| Richard A. Kendall | 1 | 1 |
| Peter G. Beemsterboer | 1 | 1 |
| Peter Beemsterboer | 1 | 1 |
| Jeffrey Basham | 1 | 1 |
| Kendall Richard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.